EP4167976A4 - Nanopartikelverkapselte cannabinoiden und verfahren zur herstellung und verwendung davon - Google Patents

Nanopartikelverkapselte cannabinoiden und verfahren zur herstellung und verwendung davon Download PDF

Info

Publication number
EP4167976A4
EP4167976A4 EP21826754.0A EP21826754A EP4167976A4 EP 4167976 A4 EP4167976 A4 EP 4167976A4 EP 21826754 A EP21826754 A EP 21826754A EP 4167976 A4 EP4167976 A4 EP 4167976A4
Authority
EP
European Patent Office
Prior art keywords
nanoparticle
production
methods
encapsulated cannabinoids
cannabinoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP21826754.0A
Other languages
English (en)
French (fr)
Other versions
EP4167976A1 (de
Inventor
Naomie LUCAS
Eric SEIDEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nurevelation LLC
Original Assignee
Nurevelation LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nurevelation LLC filed Critical Nurevelation LLC
Publication of EP4167976A1 publication Critical patent/EP4167976A1/de
Publication of EP4167976A4 publication Critical patent/EP4167976A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5161Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Carbon And Carbon Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
EP21826754.0A 2020-06-19 2021-06-18 Nanopartikelverkapselte cannabinoiden und verfahren zur herstellung und verwendung davon Withdrawn EP4167976A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063041544P 2020-06-19 2020-06-19
PCT/US2021/037989 WO2021257935A1 (en) 2020-06-19 2021-06-18 Nanoparticle-encapsulated cannabinoids and methods for making and using same

Publications (2)

Publication Number Publication Date
EP4167976A1 EP4167976A1 (de) 2023-04-26
EP4167976A4 true EP4167976A4 (de) 2024-08-07

Family

ID=79171603

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21826754.0A Withdrawn EP4167976A4 (de) 2020-06-19 2021-06-18 Nanopartikelverkapselte cannabinoiden und verfahren zur herstellung und verwendung davon

Country Status (5)

Country Link
EP (1) EP4167976A4 (de)
AU (1) AU2021293266A1 (de)
BR (1) BR112022025912A2 (de)
CA (1) CA3183022A1 (de)
WO (1) WO2021257935A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023539703A (ja) * 2020-08-28 2023-09-15 ニューレベレイション リミテッド ライアビリティ カンパニー 治療剤及びニュートラシューティカル組成物並びにそれらを作製及び使用するための方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019159174A1 (en) * 2018-02-16 2019-08-22 Icdpharma Ltd. Colonic delivery of cannabinoids in solid solution compositions
US20200054702A1 (en) * 2017-05-01 2020-02-20 Michael Heller Methodology and Formulation for Creating a Powder of an Encapsulated Cannabis-Based Component Embedded in a Polymer Matrix
US20200138072A1 (en) * 2018-11-01 2020-05-07 Molecular Infusions, Llc Polymer-based oral cannabinoid and/or terpene formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180007924A9 (en) * 2015-05-18 2018-01-11 5071, Inc. Homogenous cannabis compositions and methods of making the same
EP3655009B1 (de) * 2017-07-20 2023-10-11 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Nanopartikelzusammensetzungen
SI25647A2 (sl) * 2018-05-09 2019-11-29 Organic Tech Dwc Llc Vodne raztopine kanabinoidov

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200054702A1 (en) * 2017-05-01 2020-02-20 Michael Heller Methodology and Formulation for Creating a Powder of an Encapsulated Cannabis-Based Component Embedded in a Polymer Matrix
WO2019159174A1 (en) * 2018-02-16 2019-08-22 Icdpharma Ltd. Colonic delivery of cannabinoids in solid solution compositions
US20200138072A1 (en) * 2018-11-01 2020-05-07 Molecular Infusions, Llc Polymer-based oral cannabinoid and/or terpene formulations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2021257935A1 *

Also Published As

Publication number Publication date
AU2021293266A1 (en) 2023-02-02
BR112022025912A2 (pt) 2023-05-02
EP4167976A1 (de) 2023-04-26
CA3183022A1 (en) 2021-12-23
WO2021257935A1 (en) 2021-12-23

Similar Documents

Publication Publication Date Title
EP3652575C0 (de) Glasfaserband und verfahren zur herstellung davon
EP4126531A4 (de) Multiaxiales integriertes geogitter und verfahren zur herstellung und verwendung davon
EP3768408A4 (de) Halloysitbasierte nanokomposite und verfahren zur herstellung und verwendung davon
EP4426314A4 (de) Pi3k-alpha-inhibitoren und verfahren zur herstellung und verwendung davon
EP4298259A4 (de) Aluminiumlegierungen und verfahren zur herstellung und verwendung davon
EP4419569A4 (de) Aminocarbonsäurefunktionalisierte saccharidpolymere und verfahren zur herstellung und verwendung davon
EP4125369A4 (de) Pongamia-proteinprodukte und verfahren zur herstellung und verwendung davon
EP4330362C0 (de) Verwendung und verfahren zur herstellung von mono-rhamnolipiden
EP4330418C0 (de) Verwendung und verfahren zur herstellung von mono-rhamnolipiden
EP3884034A4 (de) Verfahren und zusammensetzungen zur herstellung cannabinoiden
EP4360624A4 (de) Lipidnanopartikel und verfahren zur herstellung davon
EP4359420A4 (de) 25-hydroxy-cholest-5-en-3-sulfatcholin und verfahren zur herstellung und verwendungen davon
EP4422700A4 (de) Hydrogelstrukturen und verfahren zur herstellung und verwendung davon
EP4109638A4 (de) Elektrochemisches element und verfahren zur herstellung davon
EP4103700A4 (de) Bakteriophagencocktailhaltige hydrogelzusammensetzungen und verfahren zur herstellung und verwendung davon
EP4037491A4 (de) Essbare pongamiazusammensetzungen und verfahren zur herstellung und verwendung davon
EP3829533C0 (de) Sonnenschutzmittel, verwendung des sonnenschutzmittels und verfahren zur herstellung der sonnenschutzmittel
EP4429702A4 (de) Zusammensetzungen mit aminolipidverbindungen und verfahren zur herstellung und verwendung davon
EP4382661A4 (de) Kunstleder und verfahren zur herstellung davon
EP4284408A4 (de) Verfahren zur herstellung von sekretomen und verwendungen davon
EP4241796A4 (de) Biokompatibles material und verfahren zur herstellung davon
EP4269691A4 (de) Zellstoffgeformter artikel und verfahren zur herstellung davon
EP4155264A4 (de) Zusammensetzung und verfahren zur herstellung davon
EP4252540A4 (de) Gewebeförmiger proteinbestandteil und verfahren zur herstellung davon
EP4167976A4 (de) Nanopartikelverkapselte cannabinoiden und verfahren zur herstellung und verwendung davon

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031010000

Ipc: A61K0031050000

A4 Supplementary search report drawn up and despatched

Effective date: 20240708

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/51 20060101ALI20240702BHEP

Ipc: A61K 9/14 20060101ALI20240702BHEP

Ipc: A61K 31/353 20060101ALI20240702BHEP

Ipc: A61K 31/352 20060101ALI20240702BHEP

Ipc: A61K 31/05 20060101AFI20240702BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250103